Med Biogene Inc.
Description Med BioGene Inc., a life science company, engages in the development and commercialization of genomic-based clinical laboratory diagnostic tests. The companys products include LungExpress Dx, a gene expression-based test for early-stage non-small-cell lung cancer that analyzes the molecular profile of a patients tumor to provide information to assist in tailoring treatment for that specific patient; and LymphExpress Dx, a gene expression-based microarray diagnostic test for common subtypes of lymphoma. It has collaboration agreement with the University of Ottawa Heart Institute for gene expression-based blood tests for cardiovascular disease. The company also has collaboration agreements with the University Health Network and Duke University. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada. To view the detailed information, you need to SUBSCRIBE with us. |
 |